Combined Endoscopy Center, Prince of Wales Hospital
Hong Kong, 00000
NCT Number: NCT03136354
The investigators compared the perioperative, oncological, functional and immunological outcomes of endoscopic submucosal dissection against laparoscopic assisted gastrectomy for treatment of early gastric cancer. With virtually no abdominal incisions and minimal pain induced, endoscopic submucosal dissection is expected to be less invasive when compared to laparoscopic assisted gastrectomy for treatment of early gastric cancer. This study will show that endoscopic submucosal dissection is associated with a significantly better perioperative recovery and less immunological disturbance. Moreover, it will also induce a better long term outcomes as the stomach can be preserved, hence the digestive function is maintained to prevent long term functional morbidities of the gastrointestinal tract.
This study will be the unique first study in the literature to show that intramucosal early gastric cancer can be adequately treated by endoscopic submucosal dissection with better perioperative, functional and quality of life outcomes when compared to laparoscopic assisted gastrectomy.
Looking for future studies?
Notify Me16 year–80 year
All sexes
Interventional
Not applicable
Hong Kong, 00000
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 days after procedure
Time frame: 30 days
Measured by VAS pain score daily until the day of discharge by dedicated independent assessor Daily measurement until the day of discharge the type and dose of analgesic requirement is also documented
Time frame: through study completion, an average of 1 year
The number of days that patient stayed in hospital
Time frame: Up to 24 hours
The Time measured by hours from start of operation after general anesthesia until end of the operation
Time frame: From date of operation on every followup appointment until 24 months after operation
As measured by SF 36
Time frame: 30 days after procedure
Time frame: up to 5 years after operation
Time frame: up to 5 years after operation
Time frame: up to 5 years after operation
Chinese University of Hong Kong
Other
Acronym: LGE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07453433
Digestive System Diseases, Digestive System Neoplasms
Shanghai, China
View Trial DetailsNCT02738294
Digestive System Diseases, Digestive System Neoplasms
Shanghai, China
View Trial DetailsNCT04032119
Digestive System Diseases, Digestive System Neoplasms
Hong Kong
View Trial DetailsNCT03123042
Digestive System Diseases, Digestive System Neoplasms
Goyang-si, Gyeonggi-do, South Korea
View Trial Details